Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.

MLA

Gregory, Martin, et al. “Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-Anal Pouch: Results From a Multicenter US Cohort.” Inflammatory Bowel Diseases, vol. 25, no. 9, Aug. 2019, pp. 1569–76. EBSCOhost, https://doi.org/10.1093/ibd/izz030.

APA

Gregory, M., Weaver, K. N., Hoversten, P., Hicks, S. B., Patel, D., Ciorba, M. A., Gutierrez, A. M., Beniwal-Patel, P., Palam, S., Syal, G., Herfarth, H. H., Christophi, G., Raffals, L., Barnes, E. L., & Deepak, P. (2019). Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort. Inflammatory Bowel Diseases, 25(9), 1569–1576. https://doi.org/10.1093/ibd/izz030

Chicago

Gregory, Martin, Kimberly N Weaver, Patrick Hoversten, Stephen Bradley Hicks, Devin Patel, Matthew A Ciorba, Alexandra M Gutierrez, et al. 2019. “Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-Anal Pouch: Results From a Multicenter US Cohort.” Inflammatory Bowel Diseases 25 (9): 1569–76. doi:10.1093/ibd/izz030.